Stoke Therapeutics
STOK
STOK
130 hedge funds and large institutions have $640M invested in Stoke Therapeutics in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 40 increasing their positions, 41 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
+12
Holders Change %
+10.17%
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
40
Reduced
41
Closed
16
Calls
$38K
Puts
$263K
Net Calls
-$225K
Net Calls Change
+$156K
Top Buyers
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
$35M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
$22.1M |
| 3 |
RI
RTW Investments
New York
|
$56.5M |
| 4 |
BlackRock
New York
|
$64.9M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
$3.31M |
Top Sellers
| 1 |
ST
Skorpios Trust
Limassol,
Cyprus
|
$76.2M |
| 2 |
Morgan Stanley
New York
|
$37.9M |
| 3 |
Marshall Wace
London,
United Kingdom
|
$10.5M |
| 4 |
Jane Street
New York
|
$132K |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$2.8M |
